MedTrace Logo

Effect of Dexmedetomidine Infusion on Post Anesthesia Discharge Time

NCT07180810 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 82

Last updated 2025-09-23

No results posted yet for this study

Summary

A randomised control trial evaluating the effect of low dose dexmedetomidine infusion on post anesthesia discharge time in patients of day case breast cancer surgery compared with placebo infusion. The primary outcome was to compare the frequency of early discharge in each group.

Conditions

  • Post Anesthesia Discharge Time in Patients of Breast Cancer Surgery

Interventions

DRUG

Dexmedetomidine infusion low dose

low dose dexmedetomidine infusion at rate 0.6mcg/kg/hour rate .

DRUG

Group B receiving normal saline

Normal saline infusion at rate 0.6mcg/kr/hour rate

Sponsors & Collaborators

  • Shaukat Khanum Memorial Cancer Hospital & Research Centre

    lead OTHER

Principal Investigators

  • Almas nil Iqbal, FRCA · Shaukat Khanum Memorial Cancer Hospital and Research Centre, Lahore

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-09-05
Primary Completion
2025-08-20
Completion
2025-08-20

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07180810 on ClinicalTrials.gov